# Induced-T Cell Like NK Cellular Immunotherapy for Cancer Lack of MHC-I

> **NCT03882840** · PHASE1,PHASE2 · RECRUITING · sponsor: **Second Affiliated Hospital of Guangzhou Medical University** · enrollment: 60 (estimated)

## Conditions studied

- Anti-cancer Cell Immunotherapy
- T Cell and NK Cell

## Interventions

- **BIOLOGICAL:** ITNK cell therapy

## Key facts

- **NCT ID:** NCT03882840
- **Lead sponsor:** Second Affiliated Hospital of Guangzhou Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-01-01
- **Primary completion:** 2028-01-01
- **Final completion:** 2035-01-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2024-06-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03882840

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03882840, "Induced-T Cell Like NK Cellular Immunotherapy for Cancer Lack of MHC-I". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03882840. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*